Transaction · 0000950170-25-019233

Martini Gregory S.

Martini Gregory S., CFO, reported an open-market or private sale at IRONWOOD PHARMACEUTICALS INC involving 12052.000000 shares for an estimated $21211.52. Reported holdings after the transaction were 183810.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCFO
IRWDIRONWOOD PHARMACEUTICALS INC
Filing timeFeb 13
Trade dateFeb 10, 2025
Filing · SECView on SEC
InsiderProfile
% of reported position traded6.15%Shares sold ÷ (holdings after + shares sold). Estimated position before: 195,862 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

IRWD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IRWD since 2025-02-13Filed 591 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000950170-25-019233
Class A Common Stock
Transaction date
Feb 10, 2025
Filed Feb 13, 2025, 02:00 AM · 3d delay
Shares
12.0k sh
$1.76 per share
Estimated value
-$21.2k
Computed from shares × price
Holdings after
183k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale o…

  2. F2

    The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.84, inclusive. The reporting person undertakes to provide to the issu…

Original filing · 0000950170-25-019233
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IRWD